Do diabetes drugs modify the risk of pancreatic cancer?

YX Yang - Gastroenterology, 2009 - gastrojournal.org
There is a growing body of literature suggesting that type 2 diabetes mellitus (DM) may be
associated with the development of several cancers. Among these is pancreatic ductal
adenocarcinoma, the 4th leading cause of cancer mortality in the United States. 1 Pancreatic
ductal adenocarcinoma is a highly lethal cancer, with a median survival of 6 months and a 5-
year survival rate of 5%. Currently, there is no effective means to screen or prevent this
cancer. Many epidemiologic studies have investigated the association between DM and …